All-trans retinoic acid induces Thrombospondin-1 expression in acute promyelocytic leukemia cells though down-regulation of its transcription repressor, c-MYC oncoprotein

Biochemical and Biophysical Research Communications

Volumn 382, Issue 4, 2009, Pages 790-794

  Xu, Bei ^a   Liu, Peng ^a   Li, Jianyong ^a   Lu, Hua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid; c MYC; Thrombospondin 1

Indexed keywords

MYC PROTEIN; RETINOIC ACID; SHORT HAIRPIN RNA; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR;

ARTICLE; ASSAY; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; HUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; UPREGULATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; THROMBOSPONDIN 1; TRETINOIN;

EID: 64549149707     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.105     Document Type: Article

References (30)

1. Lowenberg B., Downing J.R., and Burnett A. Acute myeloid leukemia. N. Engl. J. Med. 341 (1999) 1051-1062
2. Liu P., and Han Z.C. Treatment of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide: review of clinical and basic studies. Int. J. Hematol. 78 (2003) 32-39
3. Sanz M.A., Tallman M.S., and Lo-Coco F. Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Blood 105 (2005) 3019-3025
4. Wang Z.Y., and Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111 (2008) 2505-2515
5. Melnick A., and Licht J.D. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93 (1999) 3167-3215
6. Liu P., Wang Y., Li Y.H., Yang C., Zhou Y.L., Li B., Lu S.H., Yang R.C., Cai Y.L., Tobelem G., Caen J., and Han Z.C. Adenovirus-mediated gene therapy with an antiangiogenic fragment of thrombospondin-1 inhibits human leukemia xenograft growth in nude mice. Leuk. Res. 27 (2003) 701-708
7. Chen H., Herndon M.E., and Lawler J. The cell biology of thrombospondin-1. Matrix Biol. 19 (2000) 597-614
8. Touhami M., Fauvel-Lafeve F., Da Silva N., Chomienne C., and Legrand C. Induction of thrombospondin-1 by all-trans retinoic acid modulates growth and differentiation of HL-60 myeloid leukemia cells. Leukemia 11 (1997) 2137-2142
9. Saumet A., Slimane M.B., Lanotte M., Lawler J., and Dubernard V. Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/alphavbeta3 in promyelocytic leukemia NB4 cells. Blood 106 (2005) 658-667
10. Chen X., Xu H., Yuan P., Fang F., Huss M., Vega V.B., Wong E., Orlov Y.L., Zhang W., Jiang J., Loh Y.H., Yeo H.C., Yeo Z.X., Narang V., Govindarajan K.R., Leong B., Shahab A., Ruan Y., Bourque G., Sung W.K., Clarke N.D., Wei C.L., and Ng H.H. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133 (2008) 1106-1117
11. Tikhonenko A.T., Black D.J., and Linial M.L. Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene. J. Biol. Chem. 271 (1996) 30741-30747
12. Watnick R.S., Cheng Y.N., Rangarajan A., Ince T.A., and Weinberg R.A. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 3 (2003) 219-231
13. Altucci L., and Gronemeyer H. The promise of retinoids to fight against cancer. Nat. Rev. Cancer 1 (2001) 181-193
14. Ward A.C., Loeb D.M., Soede-Bobok A.A., Touw I.P., and Friedman A.D. Regulation of granulopoiesis by transcription factors and cytokine signals. Leukemia 14 (2000) 973-990
15. Chomienne C., Fenaux P., and Degos L. Retinoid differentiation therapy in promyelocytic leukemia. FASEB J. 10 (1996) 1025-1030
16. Ozpolat B., Akar U., Steiner M., Zorrilla-Calancha I., Tirado-Gomez M., Colburn N., Danilenko M., Kornblau S., and Berestein G.L. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Mol. Cancer Res. 5 (2007) 95-108
17. Harris M.N., Ozpolat B., Abdi F., Gu S., Legler A., Mawuenyega K.G., Tirado-Gomez M., Lopez-Berestein G., and Chen X. Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia. Blood 104 (2004) 1314-1323
18. Xia L., Wurmbach E., Waxman S., and Jing Y. Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis. Leukemia 20 (2006) 1009-1016
19. Carlson C.B., Lawler J., and Mosher D.F. Structures of thrombospondins. Cell. Mol. Life Sci. 65 (2008) 672-686
20. Zhang X., and Lawler J. Thrombospondin-based antiangiogenic therapy. Microvasc. Res. 74 (2007) 90-99
21. B. Xu, and P. Liu, 5-FU pretreatment potentiates cisplatin-induced apoptosis through up-regulation of thrombospondin-1 in head and neck squamous cell carcinomas, Cancer Chemother Pharmacol (2008), doi:10.1007/s00280-008-0880-x, [Epub ahead of print].
22. Streit M., Velasco P., Brown L.F., Skobe M., Richard L., Riccardi L., Lawler J., and Detmar M. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am. J. Pathol. 155 (1999) 441-452
23. Bleuel K., Popp S., Fusenig N.E., Stanbridge E.J., and Boukamp P. Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. Proc. Natl. Acad. Sci. USA 96 (1999) 2065-2070
24. Li K., Yang M., Yuen P.M., Chik K.W., Li C.K., Shing M.M., Lam H.K., and Fok T.F. Thrombospondin-1 induces apoptosis in primary leukemia and cell lines mediated by CD36 and Caspase-3. Int. J. Mol. Med. 12 (2003) 995-1001
25. Mateo V., Brown E.J., Biron G., Rubio M., Fischer A., Deist F.L., and Sarfati M. Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization. Blood 100 (2002) 2882-2890
26. Roue G., Bitton N., Yuste V.J., Montange T., Rubio M., Dessauge F., Delettre C., Merle-Beral H., Sarfati M., and Susin S.A. Mitochondrial dysfunction in CD47-mediated caspase-independent cell death: ROS production in the absence of cytochrome c and AIF release. Biochimie 85 (2003) 741-746
27. Awwad R.T., Do K., Stevenson H., Fu S.W., Lo-Coco F., Costello M., Campbell C.L., and Berg P.E. Overexpression of BP1 a homeobox gene is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells. Ann. Hematol. 87 (2008) 195-203
28. Jiang G., Albihn A., Tang T., Tian Z., and Henriksson M. Role of Myc in differentiation and apoptosis in HL60 cells after exposure to arsenic trioxide or all-trans retinoic acid. Leuk. Res. 32 (2008) 297-307
29. Adhikary S., and Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6 (2005) 635-645
30. Zeller K.I., Zhao X., Lee C.W., Chiu K.P., Yao F., Yustein J.T., Ooi H.S., Orlov Y.L., Shahab A., Yong H.C., Fu Y., Weng Z., Kuznetsov V.A., Sung W.K., Ruan Y., Dang C.V., and Wei C.L. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl. Acad. Sci. USA 103 (2006) 17834-17839